)
Visual31 Oct 2025
Three decades of Rolls-Royce
Stayble Therapeutics (STABL) investor relations material
Stayble Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary20 Aug, 2025
Executive summary
Increased visibility for STA363 through scientific and partnering conferences, with strong interest and engagement from potential partners.
STA363 is being prepared for a phase 2 clinical trial targeting pain relief in herniated disc patients, following positive phase 1 results showing significant disc volume reduction.
The company successfully raised SEK 4.55 million in a directed share issue in May, with potential for an additional SEK 2.1–4.2 million if all warrants are exercised.
Financial resources are secured to support operations and partnership discussions through Q2 2026.
Financial highlights
Operating expenses for Q2 2025 were SEK 1,882k, down from SEK 3,709k in Q2 2024.
EBIT for Q2 2025 was SEK -1,860k, an improvement from SEK -3,351k in Q2 2024.
Net result for Q2 2025 was SEK -1,877k, compared to SEK -3,435k in Q2 2024.
For the first half of 2025, operating expenses were SEK 3,948k (down from SEK 7,617k), EBIT was SEK -3,904k (improved from SEK -7,250k), and net result was SEK -3,921k (improved from SEK -7,069k) year-over-year.
Cash and cash equivalents at June 30, 2025, were SEK 5,651k.
Outlook and guidance
The company aims to finalize phase 2b study plans and continue partnership discussions, with sufficient capital to operate until Q2 2026.
Ongoing optimization of phase 2 study design with CROs and medical experts to maximize the likelihood of positive results.
Alternative and complementary partnership opportunities are being evaluated to finance and initiate the phase 2 trial as soon as possible.
How will partnerships fund Phase 2 study start?
How does STA363's volume reduction compare?
What is the expected utilization rate of TO3?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Stayble Therapeutics earnings date
Q3 202519 Nov, 2025
Next Stayble Therapeutics earnings date
Q3 202519 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Stayble Therapeutics is a clinical-stage biotechnology company developing non-surgical treatments for chronic disc-related back pain. Its lead candidate targets degenerative disc disease using injectable therapeutics. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq First North Growth Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage